Pasireotide treatment significantly improves clinical signs and symptoms in patients with Cushing's disease: results from a Phase III study

Date
2014
Author
Petersenn, Stephan
Schopohl, Jochen
Lacroix, Andre
Salgado, Luiz R.
Hughes, Gareth
Trovato, Andrew
Maldonado, Mario
Gu, Feng
Findling, James W.
Pivonello, Rosario
Newell-Price, John
Biller, Beverly M. K.
Metadata
Show full item record
Abstract
Objective Signs and symptoms of Cushing's disease are associated with high burden of illness. In this analysis, we evaluated the effect of pasireotide treatment on signs and symptoms in patients with Cushing's disease.
URI
http://hdl.handle.net/20.500.12627/108514
https://doi.org/10.1111/cen.12431
Collections